Welcome to our dedicated page for AlphaVest Acquisition SEC filings (Ticker: ATMV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AlphaVest Acquisition Corp (NASDAQ: ATMV) SEC filings page provides access to the company’s regulatory disclosures as a special purpose acquisition company. As a blank check company formed to complete a business combination with one or more businesses, AlphaVest’s filings with the U.S. Securities and Exchange Commission offer detailed information about its capital structure, trust account, shareholder votes, and proposed transactions.
Current reports on Form 8-K describe key events such as the execution and amendment of the Business Combination Agreement with AMC Corporation, the termination of a prior business combination agreement with Wanshun Technology Industrial Group Limited, and the approval of extensions to the deadline for completing a business combination. Other 8-K filings outline shareholder redemption activity, amendments to the company’s charter and trust agreement, and the entry into a forward purchase agreement intended to provide access to additional non-dilutive growth capital in connection with the proposed AMC transaction.
Periodic reports, including Forms 10-Q and related notifications such as the NT 10-Q for the quarter ended September 30, 2025, explain AlphaVest’s financial reporting status and any delays in filing. These documents, together with the company’s registration statements and proxy statements referenced in its filings, provide context on the trust account balance, redemption mechanics, and the conditions required to close its business combination.
On Stock Titan, these SEC filings are updated as they are made available through EDGAR. AI-powered summaries help interpret complex sections of 8-Ks, proxy statements, and registration statements, highlighting items such as extension approvals, redemption terms, and forward purchase arrangements. Users can quickly see how each filing affects ATMV’s timeline, capital structure, and proposed combination with AMC Corporation, while still having access to the full original documents for detailed review.
AlphaVest Acquisition Corp (ATMV) reported a much weaker Q3 2025 as it continues to pursue a business combination with AMC Corporation. For the three months ended September 30, 2025, the company posted a net loss of $2,651,350, compared with net income of $502,021 a year earlier, driven by sharply higher formation and operating costs of $2,816,519 and lower interest income from its trust assets.
Total assets were $18,955,577, mainly $18,929,689 held in a trust escrow account, while current liabilities rose to $5,264,797, including an accrued underwriting discount of $2,415,000 and related- and third-party promissory notes. Ordinary shares subject to possible redemption totaled $18,929,689 (1,574,356 shares). Following multiple shareholder redemptions tied to extension and merger votes, the company reported 3,220,947 ordinary shares outstanding as of November 19, 2025.
AlphaVest has signed a merger agreement with AMC Corporation, increasing AMC’s agreed enterprise value to $180,000,000, and its Form S-4 was declared effective in August 2025. However, management states there is substantial doubt about the company’s ability to continue as a going concern, citing a cash balance of $3,713, a working capital deficit of $5,238,909, and dependence on completing the business combination or raising additional capital.
AlphaVest Acquisition Corp. (ATMV) filed a Form 3 reporting initial beneficial ownership tied to its board. The filing lists 550,000 ordinary shares beneficially owned indirectly as of the event date 10/31/2025. The director box is checked, and the form is filed by more than one reporting person.
The shares are held by Harraden Circle funds, with Harraden Circle Investors GP, LP, Harraden Circle Investors GP, LLC, and Harraden Circle Investments, LLC in the control chain, and Frederick V. Fortmiller, Jr. as managing member. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.
AlphaVest Acquisition Corp (ATMV) reported trust account activity related to its pending business combination. The company deposited
A total of 1,399,308 ordinary shares were submitted for redemption in connection with shareholder meetings held on
AlphaVest Acquisition Corp reported two deposits of $55,000 each into its Trust Account on October 22, 2025 and October 23, 2025. Following these extension payments, the redemption value stands at approximately $12.09 per ordinary share.
The company also noted that 1,399,308 ordinary shares were submitted for redemption in connection with shareholder meetings held on September 5 and September 19, 2025, after reversal requests. In connection with these redemptions, approximately $16,917,633.70 (about $12.09 per share) will be removed from the Trust Account to pay those shareholders, subject to any additional redemption reversal requests received and approved before the closing of the business combination.
AlphaVest Acquisition Corp entered into a prepaid forward share purchase agreement tied to its planned business combination with AMC Corporation. The agreement, dated September 24, 2025, provides that Harraden Circle investment funds (collectively, the Seller) may purchase up to 500,000 shares and receive a cash prepayment at closing, funded directly from AlphaVest’s trust account based on the number of shares and commitment shares multiplied by an initial price.
After the merger closes, the Seller can, at its discretion, partially or fully unwind the position on specified trading days, paying AlphaVest an amount based on a reset price and the number of terminated shares. The arrangement matures on the earlier of 12 months after closing or a date chosen by the Seller, at which time the Seller returns the remaining shares and retains an amount equal to the shares multiplied by the initial price. The Seller has waived redemption rights on these shares, which may reduce redemptions and affect how the strength of the transaction is perceived. AlphaVest estimates a trust-account redemption price of approximately $12.02 per share as of September 24, 2025.
AlphaVest Acquisition Corp reported that shareholders approved changes to its charter and trust agreement to extend the deadline to complete a business combination. The company can now extend its original September 22, 2025 termination date up to four times, each by one month, to as late as January 22, 2026, by giving five days’ notice and depositing
Shareholders also approved an adjournment proposal, though it was not used because the main proposals passed. In connection with this meeting and a prior business combination meeting, holders of a total of 1,513,708 ordinary shares elected to redeem. After these redemptions, AlphaVest will have 2,341,148 ordinary shares outstanding, and approximately
AlphaVest Acquisition Corp. filed a current report describing an administrative update related to its shareholder meeting. On September 12, 2025, the company issued a press release announcing that it has filed supplemental proxy materials for its Extraordinary General Meeting scheduled for September 19, 2025. These supplemental materials are intended to clarify the procedures that shareholders must follow if they wish to redeem their ordinary shares in connection with the meeting.
The press release is included as Exhibit 99.1 to the report and is incorporated by reference, while the cover page Inline XBRL data is filed as Exhibit 104. The filing does not describe any change to the company’s financial results, but focuses on providing clearer instructions around the redemption process for holders of AlphaVest’s ordinary shares.
FAQ
What is the current stock price of AlphaVest Acquisition (ATMV)?
What is the market cap of AlphaVest Acquisition (ATMV)?
